| MLEC | Moolec Science SA | 0.01 | -99.51% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -98.77% |
| ENVB | Enveric Biosciences Inc | 0.08 | -95.69% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -93.47% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -92.16% |
| JAGX | Jaguar Health Inc | 0.30 | -83.43% |
| LITS | Lite Strategy Inc | 0.31 | -82.96% |
| AFMD | Affimed N.V. | 0.53 | -71.26% |
| HRTX | Heron Therapeutics Inc | 0.54 | -70.60% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -68.64% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -66.74% |
| FTRE | Fortrea Holdings Inc | 0.63 | -65.98% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -64.91% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -60.73% |
| CELU | Celularity Inc - Class A | 0.85 | -53.73% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | -52.75% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | -47.19% |
| GOSS | Gossamer Bio Inc | 0.98 | -46.87% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -39.12% |
| XLO | Xilio Therapeutics Inc | 1.14 | -38.16% |
| PTN | Palatin Technologies Inc | 1.22 | -33.48% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | -32.22% |
| FBIOP | Fortress Biotech Inc | 1.25 | -32.08% |
| HCWB | HCW Biologics Inc | 1.25 | -32.01% |
| CRIS | Curis Inc | 1.30 | -28.96% |
| IMRN | Immuron Ltd | 1.34 | -27.11% |
| CSBR | Champions Oncology Inc | 1.36 | -26.18% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -24.06% |
| RVNC | Revance Therapeutics Inc | 1.48 | -19.41% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | -18.29% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -15.46% |
| MDXG | Mimedx Group Inc | 1.61 | -12.57% |
| SPRO | Spero Therapeutics Inc | 1.61 | -12.41% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | -12.08% |
| CRMD | CorMedix Inc | 1.62 | -11.70% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -7.40% |
| AGEN | Agenus Inc | 1.71 | -7.02% |
| GLPG | Galapagos NV | 1.74 | -5.28% |
| SVA | Sinovac Biotech Ltd | 1.83 | -0.32% |
| PBYI | Puma Biotechnology Inc | 1.85 | +0.98% |
| NERV | Minerva Neurosciences Inc | 1.87 | +1.69% |
| FBIO | Fortress Biotech Inc | 1.87 | +1.96% |
| THTX | Theratechnologies Inc | 1.98 | +7.96% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | +14.97% |
| NAGE | Niagen Bioscience Inc | 2.12 | +15.36% |
| XBIO | Xenetic Biosciences Inc | 2.15 | +17.32% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | +20.75% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | +22.32% |
| NVAX | Novavax Inc | 2.32 | +26.41% |
| SPRC | SciSparc Ltd | 2.33 | +26.96% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | +32.63% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | +32.67% |
| HYFT | MindWalk Holdings Corp | 2.48 | +34.90% |
| CDXS | Codexis Inc | 2.48 | +34.95% |
| SAVA | Cassava Sciences Inc. | 2.54 | +38.11% |
| RIGL | Rigel Pharmaceuticals | 2.54 | +38.33% |
| PHAR | Pharming Group N.V. | 2.55 | +39.04% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | +41.70% |
| VRCA | Verrica Pharmaceuticals Inc | 2.62 | +42.41% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | +44.64% |
| APVO | Aptevo Therapeutics Inc | 2.70 | +47.20% |
| REVB | Revelation Biosciences Inc | 2.88 | +56.89% |
| SABS | SAB Biotherapeutics Inc | 2.96 | +61.08% |
| ARDX | Ardelyx Inc | 2.98 | +62.23% |
| CGEN | Compugen Ltd | 2.99 | +62.99% |
| VERU | Veru Inc | 3.11 | +69.30% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | +70.45% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | +70.67% |
| EVGN | Evogene Ltd | 3.17 | +72.63% |
| ICCC | Immucell Corp | 3.24 | +76.54% |
| BGMS | Bio Green Med Solution Inc | 3.28 | +78.40% |
| AAPG | Ascentage Pharma Group International | 3.28 | +78.61% |
| MNKD | Mannkind Corp | 3.32 | +80.90% |
| VALN | Valneva SE | 3.35 | +82.26% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | +82.97% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | +83.40% |
| EVAX | Evaxion Biotech A/S | 3.38 | +83.95% |
| PTHS | Channel Therapeutics Corporation | 3.41 | +85.80% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | +90.32% |
| BCAB | BioAtla Inc | 3.54 | +92.44% |
| SLDB | Solid Biosciences Inc | 3.65 | +98.43% |
| CUE | Cue Biopharma Inc | 3.66 | +99.03% |
| IPSC | Century Therapeutics Inc | 3.72 | +102.35% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | +106.81% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | +107.19% |
| INVA | Innoviva Inc | 3.81 | +107.63% |
| CLLS | Cellectis | 3.85 | +109.81% |
| LEGN | Legend Biotech Corp | 3.91 | +113.02% |
| ONCO | Onconetix Inc | 3.92 | +113.67% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | +116.94% |
| ADMA | Adma Biologics Inc | 4.03 | +119.50% |
| IMCR | Immunocore Holdings plc | 4.27 | +132.62% |
| INCY | Incyte Corp | 4.28 | +133.05% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | +134.14% |
| IVVD | Invivyd Inc | 4.31 | +134.52% |
| STRO | Sutro Biopharma Inc | 4.33 | +135.45% |
| GERN | Geron Corp | 4.51 | +145.74% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | +148.77% |
| GMAB | Genmab | 4.58 | +149.17% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | +152.60% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | +155.26% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | +156.30% |
| ABUS | Arbutus Biopharma Corp | 4.76 | +158.97% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | +159.02% |
| APLM | Apollomics Inc - Class A | 4.77 | +159.46% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | +159.73% |
| CHRS | Coherus Biosciences Inc | 4.77 | +159.73% |
| TRAW | Traws Pharma Inc | 4.77 | +159.84% |
| QTTB | Q32 Bio Inc | 4.95 | +169.69% |
| ZLAB | Zai Lab Ltd | 4.96 | +170.29% |
| DTIL | Precision Biosciences Inc | 5.04 | +174.37% |
| ACHV | Achieve Life Sciences Inc | 5.09 | +177.09% |
| VYGR | Voyager Therapeutics Inc | 5.23 | +184.71% |
| ELAB | PMGC Holdings Inc | 5.26 | +186.43% |
| PSTV | Plus Therapeutics Inc | 5.42 | +195.06% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | +196.15% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | +199.96% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | +205.40% |
| ONC | BeiGene Ltd | 5.63 | +206.49% |
| RNA | Atrium Therapeutics Inc | 5.70 | +210.30% |
| EXEL | Exelixis Inc | 5.89 | +220.64% |
| HALO | Halozyme Therapeutics Inc | 5.90 | +221.19% |
| ARVN | Arvinas Inc | 5.98 | +225.54% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | +227.49% |
| GYRE | Gyre Therapeutics Inc | 6.04 | +228.81% |
| SCPH | scPharmaceuticals Inc | 6.10 | +231.84% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | +234.25% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | +240.79% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.46 | +251.67% |
| KROS | Keros Therapeutics Inc | 6.58 | +258.21% |
| MRKR | Marker Therapeutics Inc | 6.63 | +260.93% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | +263.65% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | +275.08% |
| ANAB | AnaptysBio Inc | 6.90 | +275.63% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | +276.72% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | +288.15% |
| TCRX | Tscan Therapeutics Inc | 7.14 | +288.51% |
| RGNX | Regenxbio Inc | 7.23 | +293.59% |
| LENZ | LENZ Therapeutics Inc | 7.45 | +305.57% |
| ASMB | Assembly Biosciences Inc | 7.46 | +306.11% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | +312.10% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | +312.41% |
| ALGS | Aligos Therapeutics Inc | 7.59 | +313.19% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | +313.73% |
| PRTA | Prothena Corporation plc | 7.62 | +314.82% |
| NTBL | Notable Labs Inc Ord | 7.65 | +316.46% |
| SEER | Seer Inc - Class A | 7.83 | +326.26% |
| PTCT | PTC Therapeutics Inc | 7.83 | +326.26% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | +333.33% |
| TBPH | Theravance Biopharma Inc | 7.99 | +334.97% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | +338.78% |
| VCEL | Vericel Corp | 8.06 | +338.78% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | +341.50% |
| IMMP | Immutep Ltd | 8.12 | +342.04% |
| BNTX | BioNTech SE | 8.29 | +351.30% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | +355.11% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | +367.08% |
| ALNY | Alnylam Pharmaceuticals Inc | 8.76 | +376.88% |
| ALEC | Alector Inc | 9.04 | +392.13% |
| GOVX | Geovax Labs Inc | 9.09 | +394.85% |
| TECH | Bio-Techne Corp | 9.17 | +399.20% |
| LPCN | Lipocine Inc | 9.51 | +417.71% |
| NXTC | Nextcure Inc | 9.52 | +418.26% |
| BLRX | Bioline Rx Ltd | 9.56 | +420.43% |
| ACET | Adicet Bio Inc | 9.72 | +429.14% |
| SNGX | Soligenix Inc | 9.78 | +432.41% |
| TVTX | Travere Therapeutics Inc | 9.84 | +435.68% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | +436.22% |
| VSTM | Verastem Inc | 9.87 | +437.31% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | +438.40% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | +446.57% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +455.82% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +465.62% |
| OABI | OmniAb Inc | 10.42 | +467.25% |
| PYXS | Pyxis Oncology Inc | 10.69 | +481.95% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | +495.02% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +506.99% |
| ARGX | Argen X SE | 11.27 | +513.52% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | +517.34% |
| XNCR | Xencor Inc | 11.41 | +521.15% |
| DYAI | Dyadic International Inc DE | 11.58 | +530.40% |
| PALI | Palisade Bio Inc | 11.78 | +541.29% |
| CCCC | C4 Therapeutics Inc | 11.93 | +549.45% |
| TGTX | TG Therapeutics Inc | 12.00 | +553.27% |
| MRNA | Moderna Inc | 12.18 | +563.06% |
| XBIT | XBiotech Inc | 12.23 | +565.79% |
| CORT | Corcept Therapeutics Inc | 12.63 | +587.56% |
| MDWD | MediWound Ltd | 12.65 | +588.65% |
| ICU | SeaStar Medical Holding Corp | 12.86 | +600.08% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | +604.98% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +615.33% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | +615.33% |
| URGN | UroGen Pharma Ltd | 13.37 | +627.85% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | +636.01% |
| ANL | Adlai Nortye Ltd | 13.52 | +636.24% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | +640.37% |
| XCUR | Exicure Inc | 13.61 | +640.91% |
| CRVO | CervoMed Inc | 13.61 | +640.91% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | +644.18% |
| EDIT | Editas Medicine Inc | 13.68 | +644.72% |
| KURA | Kura Oncology Inc | 13.93 | +658.33% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | +663.23% |
| COYA | Coya Therapeutics Inc | 14.30 | +678.47% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | +681.74% |
| MGTX | MeiraGTx Holdings plc | 14.58 | +693.72% |
| XOMA | XOMA Royalty Corp | 14.63 | +696.44% |
| CVAC | CureVac N.V. | 14.83 | +707.33% |
| APLT | Applied Therapeutics Inc | 14.86 | +708.96% |
| RCUS | Arcus Biosciences Inc | 14.93 | +712.77% |
| CRBU | Caribou Biosciences Inc | 15.32 | +734.00% |
| IDYA | Ideaya Biosciences Inc | 15.70 | +754.69% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | +786.26% |
| WVE | Wave Life Sciences Ltd | 16.43 | +794.43% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | +798.24% |
| LGVN | Longeveron Inc - Class A | 16.51 | +798.78% |
| ACOG | Alpha Cognition Inc | 16.80 | +814.57% |
| AXSM | Axsome Therapeutics Inc | 17.09 | +830.36% |
| PLUR | Pluri Inc | 17.50 | +852.68% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | +855.94% |
| BEAM | Beam Therapeutics Inc | 17.79 | +868.47% |
| PRQR | ProQR Therapeutics N.V | 17.90 | +874.45% |
| IMNN | Imunon Inc | 17.94 | +876.63% |
| IPHA | Innate Pharma | 18.77 | +921.82% |
| ASND | Ascendis Pharma A/S | 20.12 | +995.31% |
| NRXS | Neuraxis Inc | 20.19 | +999.12% |
| EQ | Equillium Inc | 20.22 | +1000.75% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | +1020.35% |
| VIVS | VivoSim Labs Inc | 20.99 | +1042.67% |
| NTRB | Nutriband Inc | 21.11 | +1049.20% |
| SEPN | Septerna Inc | 21.25 | +1056.82% |
| PRLD | Prelude Therapeutics Inc | 21.25 | +1056.82% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | +1096.56% |
| ZYME | Zymeworks BC Inc | 22.33 | +1115.62% |
| CTMX | CytomX Therapeutics Inc | 22.42 | +1120.52% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | +1171.15% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +1192.92% |
| KALA | Kala Bio Inc | 23.75 | +1192.92% |
| IRD | Ocuphire Pharma Inc | 23.98 | +1205.44% |
| IGC | IGC Pharma Inc | 24.19 | +1216.87% |
| VIR | Vir Biotechnology Inc | 24.75 | +1247.36% |
| BRTX | BioRestorative Therapies Inc | 24.97 | +1259.34% |
| NBP | NovaBridge Biosciences. | 25.39 | +1282.20% |
| KRYS | Krystal Biotech Inc | 25.84 | +1306.70% |
| CGEM | Cullinan Oncology Inc | 25.86 | +1307.79% |
| ABCL | AbCellera Biologics Inc | 25.99 | +1314.86% |
| RNXT | RenovoRx Inc | 26.04 | +1317.59% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | +1339.91% |
| DARE | Dare Bioscience Inc | 26.79 | +1358.41% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +1364.40% |
| ABVC | ABVC BioPharma Inc | 27.42 | +1392.71% |
| ABEO | Abeona Therapeutics Inc | 27.67 | +1406.32% |
| BBIO | BridgeBio Pharma Inc | 27.92 | +1419.93% |
| NTLA | Intellia Therapeutics Inc | 28.12 | +1430.82% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | +1433.00% |
| INSM | Insmed Inc | 28.42 | +1447.15% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | +1498.87% |
| VRDN | Viridian Therapeutics Inc | 29.68 | +1515.74% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +1535.34% |
| ADAG | Adagene Inc | 31.61 | +1620.81% |
| MESO | Mesoblast Ltd | 33.10 | +1701.92% |
| SRZN | Surrozen Inc | 33.76 | +1737.85% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | +1772.15% |
| IMTX | Immatics N.V | 34.70 | +1789.03% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +1795.01% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | +1857.07% |
| CBIO | N/A | 36.36 | +1879.39% |
| TOVX | Theriva Biologics Inc | 37.16 | +1922.94% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | +2039.44% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | +2121.65% |
| OCUL | Ocular Therapeutix Inc | 40.81 | +2121.65% |
| NKTR | Nektar Therapeutics | 41.48 | +2158.12% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +2194.59% |
| HYPD | Eyenovia Inc | 43.89 | +2289.32% |
| EVMN | Evommune Inc | 44.84 | +2341.03% |
| MCRB | Seres Therapeutics Inc | 45.04 | +2351.92% |
| BYSI | BeyondSpring Inc | 45.99 | +2403.64% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | +2406.36% |
| TRDA | Entrada Therapeutics Inc | 47.22 | +2470.60% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +2513.61% |
| KRRO | Korro Bio Inc | 48.91 | +2562.60% |
| SPRB | Spruce Biosciences Inc | 49.19 | +2577.84% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +2667.12% |
| PPBT | Purple Biotech Ltd | 51.90 | +2725.25% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +2758.04% |
| ALLR | Allarity Therapeutics Inc | 53.04 | +2787.43% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +2809.25% |
| FATE | Fate Therapeutics Inc | 55.18 | +2903.93% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | +2925.16% |
| VYNE | VYNE Therapeutics Inc | 55.68 | +2931.15% |
| PGEN | Precigen Inc | 57.77 | +3044.93% |
| IBRX | ImmunityBio Inc | 57.87 | +3050.37% |
| STOK | Stoke Therapeutics Inc | 58.07 | +3061.26% |
| COCP | Cocrystal Pharma Inc | 58.22 | +3069.43% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +3090.11% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +3157.62% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +3241.45% |
| NBTX | Nanobiotix | 62.26 | +3289.36% |
| OVID | Ovid Therapeutics Inc | 64.47 | +3409.67% |
| ACIU | AC Immune SA | 65.70 | +3476.63% |
| EPIX | Essa Pharma Inc | 65.79 | +3481.41% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +3529.98% |
| NRIX | Nurix Therapeutics Inc | 67.32 | +3564.82% |
| JANX | Janux Therapeutics Inc | 71.18 | +3774.95% |
| ADXN | Addex Therapeutics Ltd | 71.50 | +3792.37% |
| APRE | Aprea Therapeutics Inc | 73.15 | +3882.20% |
| IVA | Inventiva | 73.66 | +3909.96% |
| LEXX | Lexaria Bioscience Corp | 75.14 | +3990.53% |
| SILO | SILO Pharma Inc | 76.31 | +4054.22% |
| OMER | Omeros Corporation | 76.82 | +4081.99% |
| MAZE | Maze Therapeutics Inc | 81.33 | +4327.51% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | +4432.03% |
| IMA | Ikena Oncology Inc | 83.32 | +4435.84% |
| TNGX | Tango Therapeutics Inc | 86.42 | +4604.60% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +4611.68% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | +4724.91% |
| OGEN | Oragenics Inc | 89.28 | +4760.29% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | +4770.64% |
| HUMA | Humacyte Inc | 90.61 | +4832.70% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +4900.75% |
| CVM | Cel-Sci Corp | 92.88 | +4956.27% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +5037.39% |
| RAPP | Rapport Therapeutics Inc | 95.49 | +5098.36% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +5189.27% |
| HIND | ReShape Lifesciences Inc | 104.32 | +5579.05% |
| MREO | Mereo Biopharma Group Plc | 104.68 | +5598.65% |
| CYTK | Cytokinetics Inc | 105.12 | +5622.60% |
| OCGN | Ocugen Inc | 108.42 | +5802.25% |
| RLYB | Rallybio Corp | 109.04 | +5836.00% |
| AIM | AIM ImmunoTech Inc. | 112.05 | +5999.86% |
| MNOV | Medicinova Inc | 113.02 | +6052.67% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | +6105.48% |
| SKYE | Skye Bioscience Inc | 117.90 | +6318.33% |
| UPB | Upstream Bio Inc | 119.09 | +6383.11% |
| GRDX | Entero Therapeutics Inc | 119.29 | +6394.00% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +6405.43% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +6673.82% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | +7667.87% |
| OPT | Opthea Ltd | 151.40 | +8141.83% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | +8202.46% |
| DBVT | DBV Technologies | 153.33 | +8247.10% |
| PRME | Prime Medicine Inc | 156.26 | +8406.60% |
| MOLN | Molecular Partners AG | 156.56 | +8422.93% |
| QURE | uniQure N.V. | 157.78 | +8489.35% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | +8919.42% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +9148.06% |
| CRDF | Cardiff Oncology Inc | 175.81 | +9470.88% |
| KYMR | Kymera Therapeutics Inc | 182.36 | +9827.45% |
| GRCE | Acasti Pharma Inc | 197.75 | +10665.27% |
| LSTA | Lisata Therapeutics Inc | 200.88 | +10835.66% |
| GTBP | GT Biopharma Inc | 204.96 | +11057.77% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | +11485.66% |
| SER | AgeX Therapeutics Inc | 224.96 | +12146.55% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | +12224.94% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | +12861.33% |
| AZTR | Azitra Inc | 239.97 | +12963.67% |
| GANX | Gain Therapeutics Inc | 255.50 | +13809.11% |
| CMPX | Compass Therapeutics Inc | 269.28 | +14559.27% |
| ATYR | Atyr Pharma Inc | 275.73 | +14910.40% |
| CYBN | Cybin Inc | 278.25 | +15047.59% |
| IBIO | iBio Inc | 279.86 | +15135.24% |
| YDES | YD Bio Ltd | 315.05 | +17050.94% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | +17309.52% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | +17357.97% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +18870.28% |
| VRNA | Verona Pharma Plc | 350.73 | +18993.32% |
| AUTL | Autolus Therapeutics plc | 372.63 | +20185.52% |
| ANIX | Anixa Biosciences Inc | 377.78 | +20465.88% |
| RLAY | Relay Therapeutics Inc | 398.28 | +21581.87% |
| TENX | Tenax Therapeutics Inc | 414.72 | +22476.85% |
| CADL | Candel Therapeutics Inc | 436.42 | +23658.17% |
| ALMS | Alumis Inc | 437.16 | +23698.45% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +25935.89% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +26653.94% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +29230.52% |
| TVRD | Cara Therapeutics Inc | 559.61 | +30364.48% |
| IMRX | Immuneering Corp Class A | 563.62 | +30582.78% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +30699.28% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +31670.47% |
| SLN | Silence Therapeutics Plc | 588.32 | +31927.42% |
| STTK | Shattuck Labs Inc | 608.39 | +33020.01% |
| LNAI | Lunai Bioworks Inc | 645.16 | +35021.72% |
| IMNM | Immunome Inc | 646.50 | +35094.67% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +35297.18% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +35647.77% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +37777.95% |
| OCS | Oculis Holding AG | 705.51 | +38307.10% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +39500.94% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +39760.61% |
| INMB | INmune Bio Inc | 760.34 | +41291.98% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +43073.21% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +44170.70% |
| SNTI | Senti Biosciences Inc | 852.38 | +46302.52% |
| COGT | Cogent Biosciences Inc | 861.15 | +46779.95% |
| PROK | ProKidney Corp - Class A | 876.39 | +47609.58% |
| ABSI | Absci Corp | 900.52 | +48923.20% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +51787.77% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +55943.08% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +64968.49% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +65835.70% |
| IBO | Impact BioMedical Inc | 1260.68 | +68529.87% |
| CGON | Cg Oncology Inc | 1269.73 | +69022.54% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +69329.58% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +71762.45% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +79328.89% |
| ENTX | Entera Bio Ltd | 1547.08 | +84121.14% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +91855.25% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +93119.32% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +101812.65% |
| MBIO | Mustang Bio Inc | 2205.73 | +119977.24% |
| ABVX | Abivax | 2425.97 | +131966.83% |
| PULM | Pulmatrix Inc | 2459.21 | +133776.38% |
| BCDA | BioCardia Inc | 2520.59 | +137117.83% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +150702.48% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +163658.91% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +167126.11% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +189147.69% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +189217.91% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +191161.92% |
| CMRX | Chimerix Inc | 3613.35 | +196606.32% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +198255.84% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +211738.14% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +218538.09% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +222451.15% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +276773.43% |
| IFRX | InflaRx N.V. | 6161.81 | +335341.38% |
| GUTS | Fractyl Health Inc | 7575.74 | +412314.00% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +423671.01% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +461316.36% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +489952.40% |
| RVMD | Revolution Medicines Inc | 9035.10 | +491759.76% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +537496.50% |
| ALT | Altimmune Inc | 10694.01 | +582068.79% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +613533.86% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +702400.26% |
| GNLX | Genelux Corp | 16310.70 | +887834.51% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +976788.01% |
| DSGN | Design Therapeutics Inc | 29402.82 | +1600553.46% |
| TRML | Tourmaline Bio Inc | 30893.12 | +1681683.70% |
| TIL | Instil Bio Inc | 54248.82 | +2953139.24% |
| ETNB | 89bio Inc | 111568.68 | +6073561.95% |
| EDSA | Edesa Biotech Inc | 130462.29 | +7102107.08% |
| SVRA | Savara Inc | 145272.62 | +7908363.29% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +26041694.52% |
| NKTX | Nkarta Inc | 1.00M | +54438673.71% |